Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 5
2002 7
2010 1
2012 1
2017 2
2018 4
2019 347
2020 508
2021 577
2022 529
2023 589
2024 176

Text availability

Article attribute

Article type

Publication date

Search Results

2,465 results

Results by year

Filters applied: . Clear all
Page 1
Acute Myeloid Leukemia: A Review.
Pelcovits A, Niroula R. Pelcovits A, et al. R I Med J (2013). 2020 Apr 1;103(3):38-40. R I Med J (2013). 2020. PMID: 32236160 Free article. Review.
Acute myeloid leukemia (AML) is a malignancy of the stem cell precursors of the myeloid lineage (red blood cells, platelets, and white blood cells other than B and T cells). ...
Acute myeloid leukemia (AML) is a malignancy of the stem cell precursors of the myeloid lineage (red blood cells, plate …
Diagnosis and treatment of therapy-related acute myeloid leukemia.
Strickland SA, Vey N. Strickland SA, et al. Crit Rev Oncol Hematol. 2022 Mar;171:103607. doi: 10.1016/j.critrevonc.2022.103607. Epub 2022 Jan 31. Crit Rev Oncol Hematol. 2022. PMID: 35101585 Free article. Review.
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, accounts for 7 %-8 % of AML cases and primarily occurs in elderly patients. t-AML is associated with …
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior cytotoxic, radiation, or immunosuppre …
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology.
Stubbins RJ, Francis A, Kuchenbauer F, Sanford D. Stubbins RJ, et al. Curr Oncol. 2022 Aug 30;29(9):6245-6259. doi: 10.3390/curroncol29090491. Curr Oncol. 2022. PMID: 36135060 Free PMC article. Review.
Acute myeloid leukemia (AML) is a hematologic malignancy that most frequently develops in older adults. ...
Acute myeloid leukemia (AML) is a hematologic malignancy that most frequently develops in older adults. ...
The clinical impact of the molecular landscape of acute myeloid leukemia.
Kayser S, Levis MJ. Kayser S, et al. Haematologica. 2023 Feb 1;108(2):308-320. doi: 10.3324/haematol.2022.280801. Haematologica. 2023. PMID: 36722402 Free PMC article. Review.
Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has led to remarkable advances in our understanding of the disease. ...
Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has led to remarkable advances in ou …
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future.
Choi JH, Shukla M, Abdul-Hay M. Choi JH, et al. Acta Haematol. 2023;146(6):431-457. doi: 10.1159/000531628. Epub 2023 Jul 17. Acta Haematol. 2023. PMID: 37459852 Free article. Review.
BACKGROUND: Acute myeloid leukemia (AML) is a disease of the hematopoietic system that remains a therapeutic challenge despite advances in our understanding of the underlying cancer biology in the past decade. ...
BACKGROUND: Acute myeloid leukemia (AML) is a disease of the hematopoietic system that remains a therapeutic challenge …
Driver mutations in acute myeloid leukemia.
Kishtagari A, Levine RL, Viny AD. Kishtagari A, et al. Curr Opin Hematol. 2020 Mar;27(2):49-57. doi: 10.1097/MOH.0000000000000567. Curr Opin Hematol. 2020. PMID: 31972687 Review.
PURPOSE OF REVIEW: The mutational landscape of acute myeloid leukemia (AML) has revised diagnostic, prognostic, and therapeutic schemata over the past decade. ...
PURPOSE OF REVIEW: The mutational landscape of acute myeloid leukemia (AML) has revised diagnostic, prognostic, and the …
Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions.
Su L, Shi YY, Liu ZY, Gao SJ. Su L, et al. Front Oncol. 2022 Feb 1;12:806137. doi: 10.3389/fonc.2022.806137. eCollection 2022. Front Oncol. 2022. PMID: 35178345 Free PMC article. Review.
Mutations in CCAAT enhancer binding protein A gene (CEBPA) are one of the common genetic alterations in acute myeloid leukemia (AML). Recently, the emergence of new evidence makes it necessary to reconsider the subsets and treatment of AML patients with CEBPA …
Mutations in CCAAT enhancer binding protein A gene (CEBPA) are one of the common genetic alterations in acute myeloid leuke …
Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Abaza Y, Zeidan AM. Abaza Y, et al. Cells. 2022 Jul 20;11(14):2249. doi: 10.3390/cells11142249. Cells. 2022. PMID: 35883692 Free PMC article. Review.
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many solid tumors, with limited progress made in the area of myeloid malignancies. The low mutational burden of acute myeloid leukemia (AML) is one potential reason behind the lack of ac …
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many solid tumors, with limited progress made in the area of myeloi …
Oral Manifestations and Complications in Childhood Acute Myeloid Leukemia.
Cammarata-Scalisi F, Girardi K, Strocchio L, Merli P, Garret-Bernardin A, Galeotti A, Magliarditi F, Inserra A, Callea M. Cammarata-Scalisi F, et al. Cancers (Basel). 2020 Jun 19;12(6):1634. doi: 10.3390/cancers12061634. Cancers (Basel). 2020. PMID: 32575613 Free PMC article. Review.
Acute myeloid leukemia (AML) is a heterogeneous group of diseases, whose classification is based on lineage-commitment and genetics. ...Primary oral alterations are identified in up to 90% of cases of acute myeloid leukemia and consist of …
Acute myeloid leukemia (AML) is a heterogeneous group of diseases, whose classification is based on lineage-commitment …
2,465 results